I did my home sleep study on June 14, 2021. I started using my APAP (ResMed Airsense 10 Autoset) on July 29, 2021. I am not able to do in-lab studies of any kind, including titration studies, due to severe chemical allergies. Also, I do not have a doctor at the moment due to insurance issues. I have attached an OSCAR Overview chart & my 2 most recent Daily charts. (I started using OSCAR on August 11 which is why there's less info on the Overview for the dates before that.)
My doctor prescribed APAP of 6.0-16.0 with no EPR which I used for the first 40 days of treatment. As advised by another forum, on September 8, I changed my APAP settings to 8.0-12.0 with full-time EPR of 2. On September 11, I bumped the max up to 12.2.
The details from my June 14, 2021 WatchPAT study are below. Note that my study found 4.7 central events per hour.
I will be very grateful for any feedback you all may be able to provide. Thank you!Description of Procedures
Unless otherwise noted, respiratory events were scored in accordance with recommended parameters as outlined in the AASM Manual for the Scoring of Sleep and Associated Events, Version 2.6, Chapter IX, Part 2: HSAT Utilizing Peripheral Arterial Tonometry. Unless otherwise specified, pAHI and ODI are calculated using a 3% or greater drop in SpO2 as the definition of a desaturation.
This study was performed using the WatchPat 300. Variables monitored included Peripheral Arterial Tonometry, pulse rate, oxygen saturation, actigraphy, respiratory effort, total sleep time, sleep staging*, body position, and snoring.
Findings
Study was started at 3:19:08 AM and ended at 1:06:24 PM. Total sleep time was 8 hrs, 17 min out of a total recording time of 9 hrs, 47 min, resulting in a sleep efficiency of 84.7%. Indicies are calculated using a technically valid sleep time of 8 hrs, 15 min. REM sleep accounted for 32.7% of total sleep time. The patient slept for 326.5 minutes (65.6 % TST) in the supine position, 169.0 minutes (33.9% TST) in the lateral position, and 2.0 minutes (0.4% TST) in the prone position. Pulse rate averaged 65 bpm, with a minimum of 53 bpm and a maximum of 96 bpm.
WatchPat 300 calculated a pAHI of 28.0 events per hour of sleep, an ODI of 28.0 events per hour of sleep, and a pAHIc of 4.7 events per hour of sleep. The patient experienced a pAHI of 26.8 events per hour of sleep in the supine position, a pAHI of 29.9 events per hour of sleep in the lateral position, and a pAHI of N/A in the prone position. The study also revealed a pAHI of 23.0 events per hour of sleep during NREM sleep, and a pAHI of 38.3 during REM sleep. During the test, the patient spent 1.6 minutes with SpO2 less than 89%, with a SpO2 nadir of 86%.
Scoring utilizing 4% or greater drop in SpO2 as the definition for oxygen desaturation revealed a pAHI (4%) of 24.8 events per hour of sleep and an ODI (4%) of 24.8 events per hour of sleep.
* Sleep staging for the WatchPat 300 is defined as wake; light sleep, deep sleep, and REM. Stages are derived using actigraphy in conjunction with other recorded parameters. Sleep EEG was not recorded.
Glossary
pAHI ‐ is a surrogate for Respiratory Event Index (REI) as well as apnea/hypopnea index (AHI) for the purposes of WatchPat 300 HSAT.
pAHIc ‐ is a surrogate for central apnea index (CAI) for the purposes of WatchPat 300 HSAT
ODI ‐ Oxygen Desaturation Index
ODI (4%) ‐ indicates 4% or greater oxygen desaturation index
pAHI(4%) ‐ indicates AHI was calculated using a 4% or greater desaturation for hypopneas
Technically valid sleep time ‐ total sleep time minus artifact exclusion
Interpretation
Moderate obstructive sleep apnea based on a 4% AHI/REI of 24.8/hour using SpO2 desaturation of 4% to define hypopnea and 3% AHI/REI of 28/hour using SpO2 3% desaturation to define hypopnea. Respiratory events were associated with SpO2 desaturation with a SpO2 nadir of 86%. Time spent with SpO2 < 89%: 1.6 minutes. Frequent snoring was noted. Approximately 66% of time was spent in supine position and 34% in non-supine position (supine AHI 27/hour versus non-supine AHI 30/hour).
Diagnosis (Home Sleep Study): Moderate Obstructive Sleep Apnea – G47.33